Translational PKPD modeling in schizophrenia. Predicting human receptor occupancy
PhD ceremony: Mr. M.G. Johnson, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Translational PKPD modeling in schizophrenia. Predicting human receptor occupancy
Promotor(s): prof. G.M.M. Groothuis, prof. M. Danhof
Faculty: Mathematics and Natural Sciences
The research described in the thesis of Martin Johnson aims to develop a computer model to predict the level of receptor binding of a new anti schizophrenia drug, using in vitro data and data from animal experiments of a number of existing drugs.
Schizophrenia is a severe psychiatric illness, which affects approximately 1% of the population and usually becomes manifest between the 15th and 30th year of life. The symptoms as hallucinations and hearing voices can be reduced by antipsychotic drugs. These drugs are not always sufficiently effective against the various symptoms of schizophrenia. In the development of new medicines, it is difficult to predict whether they are effective, among others, because the efficacy is dependent on the amount of the drug that reaches the brain and binds to the dopamine receptors, resulting in a blockade of the receptor. The extent to which the dopamine receptors are blocked is crucial to the success of an anti-schizophrenic treatment.
The model developed by Johnson describes the transport of the drug to the brains, and the binding to the receptor and dissociation from the receptor. The model, developed with data for the rat, was then translated to predict the receptor occupancy in humans. It may be used for the selection of a suitable first dose in man in the development of new drugs and can also be used to design more informative and more efficient clinical trials.
Last modified: | 13 March 2020 01.00 a.m. |
More news
-
23 April 2024
Nine MSCA Doctoral Network grants for FSE researchers
Nine researchers of the Faculty of Science and Engineering have received a Horizon Europe Marie Sklodowska Curie Doctoral Network grant.
-
22 April 2024
Charissa Roossien secures JTF subsidy to develop Health Tracker
Dr. Charissa Roossien (ENTEG) has successfully secured a Just Transition Fund (JTF) subsidy of 1.8 million euros to develop a Health Tracker for reliable respiratory and metabolic analysis.
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.